Is the incidence of registrable age-related macular degeneration increasing?
about
Leading causes of certification for blindness and partial sight in England & WalesVitamin E supplementation and macular degeneration: randomised controlled trial.Therapeutic targets in age-related macular diseasePegaptanib and ranibizumab for neovascular age-related macular degeneration: a systematic reviewMolecular genetic heterogeneity in autosomal dominant drusen+Psychometric evaluation of the MacDQoL individualised measure of the impact of macular degeneration on quality of lifeEvaluation of the G protein coupled receptor-75 (GPR75) in age related macular degenerationTreatment of subfoveal choroidal neovascularisation in age related macular degeneration: focus on clinical application of verteporfin photodynamic therapyDissection of genomewide-scan data in extended families reveals a major locus and oligogenic susceptibility for age-related macular degenerationAlternate serotype adenovector provides long-term therapeutic gene expression in the eye.Paradoxical improvement of visual acuity in macular disease.Development of choroidal neovascularization in rats with advanced intense cyclic light-induced retinal degenerationDifferential effects of the estrogen receptor agonist estradiol on toxicity induced by enzymatically-derived or autoxidation-derived oxysterols in human ARPE-19 cells.Genetic susceptibility to age related macular degeneration.Photobiomodulation reduces drusen volume and improves visual acuity and contrast sensitivity in dry age-related macular degeneration.Age-related macular degeneration--a genome scan in extended families.Lack of thrombospondin 1 and exacerbation of choroidal neovascularizationGenetic basis of inherited macular dystrophies and implications for stem cell therapy.Prevention of age-related macular degenerationHow big is the burden of visual loss caused by age related macular degeneration in the United Kingdom?Comparison of bevacizumab and ranibizumab in age-related macular degeneration: a systematic review and meta-analysis.Do patients with age related maculopathy and cataract benefit from cataract surgery?Ophthalmic and visual profile of guide dog owners in Scotland.Evidence of association of APOE with age-related macular degeneration: a pooled analysis of 15 studies.Progress and perspectives on the role of RPE cell inflammatory responses in the development of age-related macular degeneration.Perceived quality of health care in macular disease: a survey of members of the Macular Disease Society.Visual impairment and blindness in Europe and their prevention.Face recognition in age related macular degeneration: perceived disability, measured disability, and performance with a bioptic device.Knowledge about cataract, glaucoma, and age related macular degeneration in the Hong Kong Chinese population.CNV subtype in first eyes predicts severity of ARM in fellow eyes.Cost effectiveness of photodynamic therapy with verteporfin for age related macular degeneration: the UK case.Reduced vision in older adults with age related macular degeneration interferes with ability to care for self and impairs role as carer.Enhanced low vision rehabilitation for people with age related macular degeneration: a randomised controlled trial.Smoking and age related macular degeneration: the number of pack years of cigarette smoking is a major determinant of risk for both geographic atrophy and choroidal neovascularisationTrends in blind registration in the adult population of the Republic of Ireland 1996-2003.Artificial means for restoring visionAMD and micronutrient antioxidants.Visual impairment certification secondary to ARMD in Leeds, 2005-2010: is the incidence falling?Systematic review and meta-analysis of the association between complement factor H Y402H polymorphisms and age-related macular degeneration.Age-related macular degeneration and recent developments: new hope for old eyes?
P2860
Q21257225-F6C38FBE-FAD0-48BE-92B2-B5EC7B5B1BBEQ24531484-00124527-4440-4F07-9D65-E936232C2A58Q24623107-235718DD-B159-432F-9737-8392DE0DD710Q24674561-1AEC857C-8CC8-4C27-A29F-6F37FF7B9C86Q24680150-B7ED0FB0-B659-4243-BBFA-CB2F7B37C2FBQ24803944-68A77055-7B1A-4E13-A159-0B9EB40B2CBFQ28344701-B16A0716-7895-4FAF-A324-19079F8FB42FQ28361141-3303266E-D5AA-4CE1-BAA1-7E5779ACDE91Q28769548-3218D666-5503-4A43-905C-D26ABEF69FFDQ33397385-9F1A0004-52D5-46CD-8D83-81B0783E16B8Q33624053-957E34BE-EBE0-450A-933F-584D569C2DC9Q33645725-6D8CE17C-07FB-4D98-8C33-8A557240BE65Q33795949-E0F6A327-C00B-48DE-A818-C6DA0B3A9B02Q33831396-88889473-BAD7-49EF-B39B-138C925EDB96Q33834227-A4564023-2DA0-4A69-8A6C-B3EEB24E8576Q33906317-713C1E90-D2F0-439F-9024-5BB886A856AEQ34122564-56E9E76D-E580-42A9-B717-3941B6796444Q34234455-6A9E5742-AD4A-4D65-BE0A-7044B5295623Q34491498-EBDA04E4-E114-4A8D-BB6A-33010AFF2C98Q35070975-0019E4D6-A86A-4FB7-BCDD-F4B5A486A7BFQ35162123-13E54A5C-6E9D-4383-8918-C6A8A4ADC94EQ35305351-A1E5D1CF-6B8A-4CCF-A329-149204216AB8Q35309411-389CE218-D7BD-4D05-950E-16BED315F47FQ35552553-983040E4-9028-4CFB-AC7E-86B62A82FE01Q35557353-2301DC8D-C1EB-4D23-821F-1F2DC8D8FDC5Q35589826-17EFE360-99F0-4762-AC6B-AF7DDEAD3681Q35589840-99CC7287-C3AA-4818-9527-02F17E95BC04Q35590073-3670113C-7B63-47AA-A2C3-A71F57342845Q35590105-A0B53D7C-64D0-4391-ACBC-E349427F959FQ35590646-7BCC3DB0-B6FC-4B00-9F99-8E10BCAF0E99Q35592445-AE106AD0-605E-4CBC-9526-9905A94C918DQ35592449-DE4E2D74-9196-41DA-8D32-C02A640D0415Q35592624-523F9CDA-799F-4D44-9EC8-7DAFBB085211Q35761464-20A86DCD-79AF-4254-A7ED-B2BC5E48EDDFQ35761607-C000D935-420B-4DDF-A1FE-0B933025FB64Q35997009-38804011-476C-4CF6-BF58-D25DB7A6C475Q36069565-93376E0B-A0B8-4EAB-85D3-EAA49F0E2C9BQ36093250-45AB9689-61B5-4978-9633-07BEE1535AA5Q36564570-8C6EAB66-6BD5-4609-8462-F63D6BE3D02AQ36815473-50CC9AB9-EC9E-4B68-99F5-2099A78AFD8B
P2860
Is the incidence of registrable age-related macular degeneration increasing?
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on January 1996
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Is the incidence of registrable age-related macular degeneration increasing?
@en
Is the incidence of registrable age-related macular degeneration increasing?
@nl
type
label
Is the incidence of registrable age-related macular degeneration increasing?
@en
Is the incidence of registrable age-related macular degeneration increasing?
@nl
prefLabel
Is the incidence of registrable age-related macular degeneration increasing?
@en
Is the incidence of registrable age-related macular degeneration increasing?
@nl
P2860
P356
P1476
Is the incidence of registrable age-related macular degeneration increasing?
@en
P2093
P2860
P356
10.1136/BJO.80.1.9
P407
P577
1996-01-01T00:00:00Z